解放军医学杂志2013，Vol.38Issue(2)：166-171,6.
急性呼吸窘迫综合征的抗感染治疗研究进展
Anti-infectious treatment in acute respiratory distress syndrome
摘要
Abstract
Acute respiratory distress syndrome (ARDS) is closely correlated with infection. Severe infection, e.g., sepsis and septic shock, can result in ARDS. Ventilator associated pneumonia (VAP) is one of the common complications in ARDS related infection. As regards ARDS related infection, community acquired infection (CAI) is different from hospital acquired infection (HAI) in bacterial spectrum. The former is mainly caused by Streptococcus pneumonia, Hemophilus influenzae, Moraxelle catarrhalis, atypical pathogens and Klebsiella pneumoniae. However, HAI is mainly caused by Pseudomonas aeruginosa, Acinetobacter baumanii, methicillin-resistant Staphylococcus aureus (MRSA), and other drug-resistant bacteria. The drug-resistant bacterial infection not only makes treatment difficult, but also leads to an increase in mechanical ventilation time, length of ICU stay, mortality rate, and medical costs. The present paper has reviewed the relationship between ARDS and infection, therapeutic principles and measures of ARDS related infection, and introduced the optimal strategy of anti-infectious treatment of ARDS.关键词
呼吸窘迫综合征,成人/感染/治疗Key words
respiratory distress syndrome, adult/ infection/ therapyc分类
医药卫生引用本文复制引用
高敏..急性呼吸窘迫综合征的抗感染治疗研究进展[J].解放军医学杂志,2013,38(2):166-171,6.基金项目
国家自然科学基金(81171869/H2101) （81171869/H2101）
成都军区"十二五"课题(C12034) （C12034）
